Emerging serine-threonine kinase inhibitors for treating ovarian cancer

ABSTRACTIntroduction: Ovarian cancer is the leading cause of gynecologic cancer death, owing to high rates of incurable, recurrent disease after initial treatment. Serine threonine kinases (STKs) h...